Efficacy of diltiazem administration on the respiratory adverse effects of enalapril Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002
Can CPAP reduce adverse cardiovascular and metabolic effects of OSAS? Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007
The safety of LAMA/LABA combination therapy for the ocular and urinary adverse effects in the COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
Cardiovascular adverse effects during itraconazole therapy Source: Eur Respir J 2008; 32: 240 Year: 2008
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016 Year: 2017
Low-dose amiodarone therapy may be responsible of serious adverse pulmonary effects in patients without pre-existing lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004
Predictors of effects and adverse effects of pirfenidone on idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Severe adverse effects of antitubercular drugs and patient management Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005
Adherence to inhaled controller therapy and local adverse events in children with asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Possible neuropsychic adverse reactions with montelukast in childhood asthma Source: Eur Respir J 2001; 18: Suppl. 33, 263s Year: 2001
Acute health effects of short-term use of e-cigarette on respiratory and cardiovascular system Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) Year: 2018
The effects of climate changes and extreme events on respiratory allergy Source: International Congress 2014 – ERS/World Allergy Organisation "Climate change, air pollution and respiratory diseases" Year: 2014
Absence of respiratory effects in asthmatic subjects with the If inhibitor ivabradine, a novel anti-anginal agent Source: Eur Respir J 2006; 28: Suppl. 50, 664s Year: 2006
Modelling the beneficial impact of inhaled corticosteroids on health outcomes among COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004
Long-term safety of medium- and high-dose mometasone furoate/formoterol combination in persistent asthmatics: Analysis of adverse event incidence, plasma cortisol, and ocular changes Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010
The impact of preventive treatment with long-acting β2 adrenergics agonists and inhaled glucocorticoids in the morbility and mortality of 1.543 events of severe acute exacerbations of asthma Source: Annual Congress 2009 - Epidemiology of atopy and asthma Year: 2009
Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF Source: Eur Respir J 2015; 46: 1217-1221 Year: 2015
The importance of differentiating behavioural and psychological treatment effects from placebo in respiratory interventions Source: Eur Respir J, 53 (4) 1900156; 10.1183/13993003.00156-2019 Year: 2019
Respiratory adverse effects in oncology nurses exposed to antineplastic drugs Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies Year: 2015